搜索结果: 1-15 共查到“知识库 肿瘤学 CELL”相关记录55条 . 查询时间(0.171 秒)
肝癌是中国高发恶性肿瘤。由于其广泛的肿瘤异质性，最新的靶向联合免疫治疗的方案仅对20~30%的患者有效，并且缺乏指导精准用药的药敏分子分型。因此亟需研究可以指导肝癌精准用药的分子分型和揭示新的耐药靶点。
Hippo信号通路在肿瘤发生发展中发挥重要作用，其效应蛋白YAP/TAZ转录辅助因子在多种肿瘤中显著激活[1, 2]。因此，靶向Hippo通路的肿瘤治疗策略具有很好的临床转化前景。然而，目前尚无相关药物真正进入临床用于肿瘤治疗[3]。近年来，基于抗体和细胞的靶向疗法方兴未艾，如果能鉴定出一种体现Hippo通路活性的细胞表面标志物，将为靶向Hippo通路的肿瘤治疗带来全新可能性。
Hippo信号通路参与肿瘤发生、发展、耐药等不同阶段，是一个理想的肿瘤治疗靶点。近年来，开发靶向Hippo通路的抗癌疗法已成为一个研究热点，但目前尚没有相关药物进入临床。明确Hippo通路调控机制是分子靶向治疗研发的重要基础。然而，Hippo领域近二十年的研究主要聚焦于通路组分的鉴定及功能解析，分子机制研究则相对滞后。
髓母细胞瘤是儿童最常见的颅脑恶性胚胎性肿瘤，世界范围的发病率为每年5.07-6.8/10万人，是引起儿童肿瘤相关死亡的首要原因。目前针对髓母细胞瘤的治疗是一种联合治疗的策略，手术为主，综合放疗以及化疗、靶向药物治疗等作为辅助治疗。髓母细胞瘤的发病机理极其复杂，涉及表观遗传学、胚胎发育学等多个方面，目前尚未完全明确，导致总体治疗效果并不是非常理想。
2021年1月11日，上海交通大学医学院上海市免疫学研究所邹强团队联合邓刘福团队、上海交通大学医学院附属瑞金医院王正廷副主任医师团队在国际著名期刊Molecular Cell在线发表了题为“SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function”的研究论文。该研究发现...
Researchers link HIV susceptibility to little-understood immune cell class
Researchers HIV susceptibility immune cell class
2015/8/4
High diversity among certain cells that help fight viruses and tumors is strongly associated with the likelihood of subsequent infection by HIV, Stanford University School of Medicine resear...
Epithelioid Cell Histiocytoma–An Unusual Variant of Dermatofibroma at an Uncommon Site
Epithelioid cell histiocytoma Nose
2015/7/22
Epithelioid cell histiocytoma (ECH) is a rare variant of cutaneous fibrous histiocytoma involving primarily trunk and the extremities. It can delude the pathologist in considering other benign non neo...
Emperipolesis in a Case of Adult T Cell Lymphoblastic Lymphoma (Mediastinal type)-Detected at FNAC and Imprint Cytology
Emperipolesis Lymphoblastic lymphoma Imprint cytology Rosai Dorfman disease
2015/7/22
Emperipolesis is a condition in which viable hematopoetic cells are seen intact in the cytoplasm of host cell without damage. This phenomenon is seen in many physiologic and pathologic conditions, its...
Multilocular Cystic Renal Cell Carcinoma:An Unusual Gross Appearance
Multilocular Cystic renal Cell Carcinoma Renal Cell Carcinoma
2015/7/21
Multilocular Cystic Renal Cell Carcinoma (MCRCC) represents a rare variant of clear cell (conventional) renal cell carcinomas. Attributable to its distinct characteristics in prognosis and its natural...
Renal cell carcinoma is the most common neoplasm of the kidney comprised of different histological variants. Chromophobe renal cell carcinoma (ChRCC) is a rare subtype of renal cell carcinoma (RCC) ma...
Cytomorphological Diagnosis of Giant Cell Tumour of Distal End Radius in Elderly Patient
Benign bone tumour Cytology Giant cell tumour
2015/7/10
Giant cell tumours (GCTs) of bone have been described as the most challenging benign bone tumors. It is very unusual for GCT to occur in patients younger than 20 yrs or older than 55 years. GCT is see...
Metastatic Renal Cell Carcinoma in the Sinonasal Region
Sinonasal region Metastatic renal cell carcinoma Diagnosis
2015/7/10
Sinonasal region is an exceptional site for metastatic tumors. Renal cell carcinoma is known to metastasise to the most unusual sites, the sinonasal region being one of them. Clear cell carcinoma is i...
New systemic treatment options for advanced basal cell carcinoma
treatment options cell carcinoma
2015/4/7
Basal cell carcinoma is a very common skin malignancy that is usually able to be cured by simple local treatment
(surgical excision, radiotherapy or cryotherapy). However, patients sometimes present...
Merkel cell carcinoma is a rare, aggressive, cutaneous neuroendocrine tumour which has a propensity for both locoregional and distant spread. This review considers its epidemiology, diagnosis, staging...
The landscape of treatment for renal cell carcinoma has changed radically over the last few years. Previously, the most effective treatments were too toxic, too expensive or too ineffective. Careful b...